15 October 2019

In Israel you simply sign a contract and send it per email

Our partner Dr. Katy Ritzmann reports on the Technology Hotspot Israel and the different legal structures for investors in Germany and Israel in an interview with VentureCapital Magazin.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 02 February 2023

    GSK Update: The new Transparency International Corruption Perceptions Index 2022

    Read more
  • 23 November 2022

    GSK Update: FAQs on the most important PRIIP requirements as of 01.01.2023

    Read more
  • 06 October 2022

    GSK Update: Real estate transfer tax on share deals – how to approach potential double taxation issues

    Read more
Contact person

Dr. Katy Ritzmann

Partner*

+49 30 203907-422

katy.ritzmann@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral